600664.SHG Harbin Pharmaceutical Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
5.80 CNY
Close of Nov 5, 2026
2.84 9.86
Market cap
CNY 14.6B
P/E
23.2x
P/B
2.19x
ROE
12.7%
Dividend yield
0.23%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600664.SHG undervalued?

Graham number
Price5.80
Graham value3.86
Premium50.3%

600664.SHG trades 50.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Harbin Pharmaceutical Group Co Ltd fundamental analysis

No fundamental analysis for Harbin Pharmaceutical Group Co Ltd yet.

Harbin Pharmaceutical Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Harbin Pharmaceutical Group Co Ltd

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, antiviral and anti-infective, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supp…

Full company profile